<DOC>
	<DOCNO>NCT00006349</DOCNO>
	<brief_summary>RATIONALE : Donepezil vitamin E may able decrease side effect cause radiation therapy give prevent brain metastases patient small cell lung cancer . It yet know donepezil vitamin E effective prevent side effect cause radiation therapy head . PURPOSE : Randomized phase III trial determine effectiveness donepezil vitamin E prevent side effect cause radiation therapy give prevent brain metastases patient small cell lung cancer .</brief_summary>
	<brief_title>Donepezil Vitamin E Prevent Side Effects Caused By Radiation Therapy Head Patients Receiving Treatment Small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare interval completion cancer treatment include prophylactic cranial irradiation onset cognitive decline patient small cell lung cancer ( SCLC ) treat donepezil vitamin E v placebo . - Determine toxicity donepezil vitamin E patient . - Determine whether preserved cognitive function favorably impact quality life patient . - Determine natural history cognitive decline patient cancer treatment . - Determine whether genotype apolipoprotein E predict decline cognitive function among patient risk treatment-associated dementia whether genotype predict duration disease-free survival among patient achieve complete response treatment SCLC . OUTLINE : This randomize , double-blind , placebo-controlled study . Patients stratify accord cognitive function ( normal v mild moderate dysfunction v severe dysfunction ) age ( 60 vs 60 ) . Patients randomize 1 2 treatment arm . - Arm I : Patients receive oral donepezil daily vitamin E twice daily . - Arm II : Patients receive oral placebo accord schedule study drug arm I . All patient begin treatment within 2 week completion prophylactic cranial irradiation . Treatment continue minimum 1 month absence disease progression , unacceptable toxicity , 3.0 point drop Mini Mental State Examination ( MMSE ) and/or 5 point drop Blessed Dementia Scale . Cognition assess use Blessed Dementia Scale MMSE baseline every 3 month study . Quality life depression assess baseline every 3 month study . Patients follow every 6 month .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Delirium</mesh_term>
	<mesh_term>Radiation Injuries</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis small cell lung cancer ( SCLC ) Must meet one follow condition : Enrolled 4 week initiation prophylactic cranial irradiation ( PCI ) OR Enrolled 10 day initiation PCI Limited extensive stage SCLC complete response ( CR ) outside chest allow Must CR minimal disease completion intend course chemotherapy No disease progression since initiation PCI No prior concurrent CNS metastases PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Life expectancy : At least 12 week Hepatic : Bilirubin great 1.5 mg/dL Renal : Creatinine great 2 time upper limit normal Cardiovascular : No sick sinus syndrome symptomatic supraventricular conduction disorder even symptom currently control antiarrhythmic Pulmonary : No history asthma chronic obstructive pulmonary disease require chronic oxygen therapy Other : No medical psychiatric condition would increase risk No seizure disorder No ongoing alcohol abuse PRIOR CONCURRENT THERAPY : Chemotherapy : See Disease Characteristics No concurrent anticancer chemotherapy Other : No concurrent medication would impair baseline cognitive function likely dose escalate next month No concurrent vitamin E</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>depression</keyword>
	<keyword>delirium</keyword>
	<keyword>cognitive/functional effect</keyword>
	<keyword>radiation toxicity</keyword>
	<keyword>limited stage small cell lung cancer</keyword>
	<keyword>extensive stage small cell lung cancer</keyword>
	<keyword>recurrent small cell lung cancer</keyword>
</DOC>